24/7 Live
New York City
New Jersey
Long Island
Northern Suburbs
Connecticut
Welcome, Mickey
mickey@disney.com
Manage MyDisney Account
Log Out
7-Day Forecast
TV Listings
Live
The Loop
Latest
CEO Killed
Congestion Pricing
Holiday Guide
Podcasts
Submit News Tips
weight loss
Share
Tweet
Email
FDA approves 1st medication for obstructive sleep apnea
The new approval means that insurance providers will likely cover the medication for people with sleep apnea and obesity.
US obesity rates drop for 1st time in a decade
Biden proposes Medicare and Medicaid cover costly weight-loss drugs
Jelly Roll's chef opens up about singer's 100-pound weight loss
Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
Weight loss drugs like Ozempic may help reduce overdose risks: Study
Ozempic producer CEO in hot seat in congressional hearing
More Stories
Obesity prevalence among US adults falls slightly to 40%: CDC
Extra Time: Eli Lilly to sell Zepbound to consumers without insurance
Eli Lilly to sell Zepbound directly to consumers without insurance
Some people are overdosing on semaglutide, FDA warns
Nearly half of US adult cancer deaths could be prevented, study finds
Pfizer targets obesity with new once-daily Danuglipron drug
Weight-loss, diabetes meds linked to lower risk of some cancers: Study
Up Close 7/7/24: Will NYC schools ban cellphones?
Eli Lilly warns about dangers of fake Mounjaro, Zepbound
Extra Time: Israel releases video of Hamas kidnapping 5 hostages
Current weight loss drug users: slightly more women, people with health insurance
New Wegovy clinical trial finds surprising benefits beyond weight loss
Show More
Show Fewer
More Stories
US obesity rates drop for 1st time in a decade
Biden proposes Medicare and Medicaid cover costly weight-loss drugs
Jelly Roll's chef opens up about singer's 100-pound weight loss
Ingredient in Ozempic, Wegovy may reduce risk of Alzheimer's: Study
Weight loss drugs like Ozempic may help reduce overdose risks: Study
Ozempic producer CEO in hot seat in congressional hearing
Obesity prevalence among US adults falls slightly to 40%: CDC
Extra Time: Eli Lilly to sell Zepbound to consumers without insurance
Eli Lilly to sell Zepbound directly to consumers without insurance
Some people are overdosing on semaglutide, FDA warns
Nearly half of US adult cancer deaths could be prevented, study finds
Pfizer targets obesity with new once-daily Danuglipron drug
Weight-loss, diabetes meds linked to lower risk of some cancers: Study
Up Close 7/7/24: Will NYC schools ban cellphones?
Eli Lilly warns about dangers of fake Mounjaro, Zepbound
Extra Time: Israel releases video of Hamas kidnapping 5 hostages
Current weight loss drug users: slightly more women, people with health insurance
New Wegovy clinical trial finds surprising benefits beyond weight loss
Show More
Show Fewer